| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001982805 |
| P356 | DOI | 10.1186/1471-2407-11-238 |
| P932 | PMC publication ID | 3130705 |
| P698 | PubMed publication ID | 21668942 |
| P5875 | ResearchGate publication ID | 51215160 |
| P50 | author | Helena Carén | Q39025579 |
| Kent Lundholm | Q46900962 | ||
| P2093 | author name string | Marianne Andersson | |
| Christina Lönnroth | |||
| Kristina Lagerstedt | |||
| Annika Gustafsson Asting | |||
| P2860 | cites work | BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes | Q24794804 |
| Prostaglandins and cancer | Q28188827 | ||
| A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer | Q28195274 | ||
| Epigenetics in human disease and prospects for epigenetic therapy | Q29547437 | ||
| BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. | Q31002908 | ||
| Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. | Q34059608 | ||
| Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer | Q34111875 | ||
| Many actions of cyclooxygenase-2 in cellular dynamics and in cancer | Q34539982 | ||
| Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? | Q35858035 | ||
| Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention | Q35864033 | ||
| AP-1 and colorectal cancer | Q36301703 | ||
| Signalling networks regulating cyclooxygenase-2. | Q36483419 | ||
| The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment | Q37366259 | ||
| p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue | Q38443641 | ||
| Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression. | Q40162849 | ||
| Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. | Q40262886 | ||
| Significance of COX-2 expression in human esophageal squamous cell carcinoma | Q40340367 | ||
| Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells | Q40344093 | ||
| The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors. | Q40377433 | ||
| The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinoma | Q40522617 | ||
| Homeodomain protein CDX2 regulates COX-2 expression in colorectal cancer. | Q40580143 | ||
| Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas. | Q40627566 | ||
| Aspirin use and risk of fatal cancer | Q41085386 | ||
| Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia | Q42475362 | ||
| Receptor and enzyme expression for prostanoid metabolism in colorectal cancer related to tumor tissue PGE2. | Q43204444 | ||
| DNA methylation mapping by tag-modified bisulfite genomic sequencing | Q43481426 | ||
| Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth | Q43848555 | ||
| Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer | Q44427325 | ||
| Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated rece | Q45003981 | ||
| Growth associated proteins in tumor cells and stroma related to disease progression of colon cancer accounting for tumor tissue PGE2 content. | Q46687060 | ||
| Nonsteroidal antiinflammatory drugs and colorectal cancer. | Q52882781 | ||
| Cyclooxygenase 2 Expression in Colorectal Cancer with DNA Mismatch Repair Deficiency | Q57239956 | ||
| Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors | Q74181079 | ||
| EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality | Q79751467 | ||
| Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression | Q81793792 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colon cancer | Q18555025 |
| P304 | page(s) | 238 | |
| P577 | publication date | 2011-06-13 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status | |
| P478 | volume | 11 |
| Q33901395 | Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades |
| Q57471502 | Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway |
| Q34252516 | Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways |
| Q37336912 | Differential sensitivity to methylated DNA by ETS-family transcription factors is intrinsically encoded in their DNA-binding domains |
| Q37722089 | Effect of ART1 on the proliferation and migration of mouse colon carcinoma CT26 cells in vivo |
| Q27014984 | Epigenetics meets radiation biology as a new approach in cancer treatment |
| Q58590446 | Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma |
| Q38464714 | Expression of COX-2, IL-1β, TNF-α and IL-4 in epithelium of serrated adenoma, adenoma and hyperplastic polyp |
| Q33599214 | FosB transcription factor regulates COX-2 expression in colorectal cancer cells without affecting PGE2 expression |
| Q57070511 | Inflammatory gene mRNA expression in human peripheral blood and its association with colorectal cancer |
| Q55260344 | Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer. |
| Q27495979 | Interaction between Chronic Inflammation and Oral HPV Infection in the Etiology of Head and Neck Cancers |
| Q64236794 | Isoalantolactone inhibits IKKβ kinase activity to interrupt the NF-κB/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma |
| Q35781503 | Ku80 cooperates with CBP to promote COX-2 expression and tumor growth |
| Q53226402 | Loss of p53 in stromal fibroblasts enhances tumor cell proliferation through nitric-oxide-mediated cyclooxygenase 2 activation. |
| Q41390309 | Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKβ/NF-κB/COX-2 signaling pathway |
| Q54939991 | Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells. |
| Q54441004 | Palmitate induces COX-2 expression via the sphingolipid pathway-mediated activation of NF-κB, p38, and ERK in human dermal fibroblasts. |
| Q34696571 | Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma. |
| Q37017061 | Relative Expression of Vitamin D Hydroxylases, CYP27B1 and CYP24A1, and of Cyclooxygenase-2 and Heterogeneity of Human Colorectal Cancer in Relation to Age, Gender, Tumor Location, and Malignancy: Results from Factor and Cluster Analysis. |
| Q38183889 | The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies |
| Q38367696 | The role of the mediators of inflammation in cancer development. |
Search more.